Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7AVY

MerTK kinase domain in complex with quinazoline-based inhbitor

7AVY の概要
エントリーDOI10.2210/pdb7avy/pdb
分子名称Tyrosine-protein kinase Mer, N-(2-(2-cyclopropylethoxy)pyrimidin-5-yl)-7-methoxy-6-(piperidin-4-ylmethoxy)quinazolin-4-amine, SULFATE ION, ... (4 entities in total)
機能のキーワードtyrosine kinase, inhibitor, type1.5 kinase inhibitor, structure-based drug design, oncology, signaling protein
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数1
化学式量合計34739.08
構造登録者
主引用文献Nissink, J.W.M.,Bazzaz, S.,Blackett, C.,Clark, M.A.,Collingwood, O.,Disch, J.S.,Gikunju, D.,Goldberg, K.,Guilinger, J.P.,Hardaker, E.,Hennessy, E.J.,Jetson, R.,Keefe, A.D.,McCoull, W.,McMurray, L.,Olszewski, A.,Overman, R.,Pflug, A.,Preston, M.,Rawlins, P.B.,Rivers, E.,Schimpl, M.,Smith, P.,Truman, C.,Underwood, E.,Warwicker, J.,Winter-Holt, J.,Woodcock, S.,Zhang, Y.
Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy.
J.Med.Chem., 64:3165-3184, 2021
Cited by
PubMed: 33683117
DOI: 10.1021/acs.jmedchem.0c01904
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.31 Å)
構造検証レポート
Validation report summary of 7avy
検証レポート(詳細版)ダウンロードをダウンロード

223532

件を2024-08-07に公開中

PDB statisticsPDBj update infoContact PDBjnumon